AI Challenges in Medicare Prior Authorization Initiatives

A Medicare initiative using artificial intelligence (AI) to review prior authorization requests has hit significant operational hurdles, causing treatment delays.

This revelation comes from documents obtained after a Freedom of Information Act lawsuit by the Electronic Frontier Foundation (EFF) against the Centers for Medicare & Medicaid Services (CMS). The initiative, known as the Wasteful and Inappropriate Service Reduction (WISeR) model, aims to streamline authorizations but is encountering growing criticism.

Operational Delays Spark Concerns

The WISeR pilot program, launched in January, operates in six states: Texas, Arizona, New Jersey, Ohio, Oklahoma, and Washington. It targets certain medical services deemed vulnerable to fraud and misuse, employing AI-enabled technology platforms handled by private contractors. However, these contractors have struggled to meet CMS's 72-hour turnaround guidance, with some authorization delays stretching to 83 days.

The EFF, highlighting such instances, notes the detrimental patient outcomes stemming from these delays. This issue raises questions about whether the AI technology was adequately tested before being rolled out in the WISeR initiative.

Provider and Patient Feedback

Providers involved in the program have reported increased administrative burdens and procedural complexity. A significant number of users have expressed frustration over system outages and prolonged waiting periods for necessary medical procedures, leading to both provider and patient dissatisfaction.

"Without robust safeguards, AI in prior authorization could contribute to unjustified delays or denials."
Electronic Frontier Foundation

CMS has acknowledged this feedback and is reportedly committed to enhancing the program's accuracy and timeliness. However, the criticism calls into question the balance between leveraging technology for efficiency and maintaining high-quality patient care.

Implications and Future Outlook

The challenges faced by the WISeR program underscore the broader industry conversation about AI's role in healthcare. Experts indicate the crucial need for thorough validation of AI systems to ensure they enhance administrative processes without compromising patient outcomes. Despite current issues, Medicare plans to continue using AI-driven solutions like WISeR through 2031.

Key Points Providers Should Monitor

• Authorization Delays: Ongoing issues with meeting CMS's 72-hour target.
• Administrative Burdens: Increased complexity reported by providers.
• Regulatory Oversight: Calls for better pre-launch testing of AI systems.

For industry professionals, the implications of such AI initiatives are critical. They must prepare for changes in claims management, compliance requirements, and potential impacts on agency operations. As Medicare and similar bodies continue to explore AI applications, the insurance industry must keep a close watch on technological efficacy and patient impact.